Funded Project Details - FY2021
|Title:|| Mitochondrial-Targeted Antioxidant-Encapsulating Nanoparticles as a Promising Therapeutic Strategy in Regulating Outflow Resistance|
Evan B. Stubbs
|Congressional District Code:
||Biomedical Laboratory R&D
|| October 2017 -
|FY 2021 Funding Amount:
|Total Award Amount
View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER
Neurodegenerative diseases, including glaucoma, substantially alter quality of life of the affected Veteran. Glaucoma remains a leading cause of irreversible blindness. Currently affecting over 60 million individuals, this insidious optic neuropathy is characterized by a gradual loss of RGC neurons and is projected to impact nearly 80 million people by the year 2020. The prevalence of primary open angle glaucoma (POAG), the most common form of glaucoma, is approximately 1.86%, or nearly 2 millio...
Questions about the R&D website? Email the Web Team
Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.